Search

Your search keyword '"Bachi, Angela"' showing total 791 results

Search Constraints

Start Over You searched for: Author "Bachi, Angela" Remove constraint Author: "Bachi, Angela"
791 results on '"Bachi, Angela"'

Search Results

7. SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA

10. Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity

15. Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse

17. Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer

20. The human nucleoporin Tpr protects cells from RNA-mediated replication stress

22. Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression

23. Clonal cooperation through soluble metabolite exchange facilitates metastatic outgrowth by modulating Allee effect

26. ATR is essential for preservation of cell mechanics and nuclear integrity during interstitial migration

30. Supplementary Table from Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients

31. Supplementary Data from Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients

33. Supplementary Figures S1-S6 from Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation

35. Data from Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation

39. Supplementary Table S1 from Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation

41. Supplementary Figure Legends from Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation

42. Supplementary Methods and References from Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation

44. 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development

50. Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

Catalog

Books, media, physical & digital resources